These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1507539)

  • 1. Potassium channel openers: effects on the vascular system.
    Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():232P-237P. PubMed ID: 1507539
    [No Abstract]   [Full Text] [Related]  

  • 2. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
    J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New activators of potassium channels: design, pharmacology and therapeutic perspectives].
    Pirotte B; Fontaine J; Lebrun P
    J Pharm Belg; 1995; 50(2-3):167-78. PubMed ID: 7674116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood pressure regulation by potassium channels].
    Orias M
    Medicina (B Aires); 1998; 58(4):429-32. PubMed ID: 9816709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of arterial tone by potassium channels.
    Nelson MT
    Jpn J Pharmacol; 1992; 58 Suppl 2():238P-242P. PubMed ID: 1507540
    [No Abstract]   [Full Text] [Related]  

  • 7. Latest developments in K-channel modulator pharmacology.
    Weston AH; Edwards G
    Z Kardiol; 1991; 80 Suppl 7():1-8. PubMed ID: 1792813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel activation, hyperpolarization, and vascular relaxation.
    Siegel G; Walter A; Schnalke F; Schmidt A; Buddecke E; Loirand G; Stock G
    Z Kardiol; 1991; 80 Suppl 7():9-24. PubMed ID: 1724332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation.
    Gutterman DD; Miura H; Liu Y
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):671-8. PubMed ID: 15705931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adenosine-triphosphate-sensitive potassium channels in the mechanical responses of agonist-stimulated isolated porcine coronary arteries.
    Nguyen DH
    Arzneimittelforschung; 1997 Dec; 47(12):1351-8. PubMed ID: 9450163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory mechanisms of action of K+ channel openers on contraction induced by an agonist in canine coronary arterial smooth muscle.
    Yanagisawa T; Yamagishi T; Taira N
    Jpn J Pharmacol; 1992; 58 Suppl 2():332P. PubMed ID: 1507581
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hypoxia on a potassium channel in cat cerebral arterial muscle cells.
    Bonnet P; Gebremedhin D; Rush NJ; Harder DR
    Z Kardiol; 1991; 80 Suppl 7():25-7. PubMed ID: 1792816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium channel diversity in vascular smooth muscle cells.
    Michelakis ED; Reeve HL; Huang JM; Tolarova S; Nelson DP; Weir EK; Archer SL
    Can J Physiol Pharmacol; 1997 Jul; 75(7):889-97. PubMed ID: 9315358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of extracellular pH on vasopressin inhibition of ATP-sensitive K+ channels in vascular smooth muscle cells.
    Kawano T; Tanaka K; Nazari H; Oshita S; Takahashi A; Nakaya Y
    Anesth Analg; 2007 Dec; 105(6):1714-9, table of contents. PubMed ID: 18042872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K(+)-channel openers: new antihypertensive drugs?
    Haeusler G
    Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ATP-sensitive K+ channels in relaxation of penile resistance arteries.
    Ruiz Rubio JL; Hernández M; Rivera de los Arcos L; Benedito S; Recio P; García P; García-Sacristán A; Prieto D
    Urology; 2004 Apr; 63(4):800-5. PubMed ID: 15072915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adenosine triphosphate-sensitive potassium channel inhibitors on coronary metabolic vasodilation.
    Farouque HM; Meredith IT
    Trends Cardiovasc Med; 2007 Feb; 17(2):63-8. PubMed ID: 17292049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.